Main Menu
ESGTI is a Swiss based company governed by experts with European and Swiss roots. Our diverse board of directors and advisory team ensure your investments provide the returns and positive impact we seek on a daily basis.
ESGTI outsources its operations on the ground in Switzerland to experts in finance, ESG investing and business strategy. These teams are portfolio managers, pipeline seekers, communicators and activists for a more sustainable world.
With ESG criteria as the backdrop for our investments and operational vision it is also crucial to embed this knowledge into daily business. We have an experienced committee of ESG and sustainability experts to ensure we embed ESG principles from pipeline investment discussions right through to measuring impact on the ground.
In parallel, knowledge for our key portfolio pillars is fed by a team of dedicated subject-matter experts. The experience of this broad team covers speciality areas of Agriculture, BioTech, Pharmaceutics, Engineering, Energy and Sustainable Financing.
Mr Dimitriou has over 35 years’ experience in the Pharmaceutical and Biotech industry and is a co-founder and former CEO of a listed biotech company. He was previously Senior Director of Worldwide Business Development at GlaxoSmithKline and spent 8 years at Procter & Gamble’s pharmaceutical division in Marketing, R&D and Business Development and began his career as Product Manager in Novartis. He has been an advisor to numerous companies in the life sciences. Dimitri has a Bachelor’s in Biochemistry from Kings College of the University of London, a Master’s in Pathology from Imperial College Medical School and is a member of numerous medical and scientific societies.
Dr Pavesi holds a PhD in Physics and has almost 40 years’ experience in high technology industries. She worked in advanced technology for 28 years in Telespazio, a Leonardo Company, as Director of Business Development and Innovative Services and other roles. Prior to this, she worked at Italspazio, Consortium for Space Activities, directing and leading international studies and projects for NASA, ESA, ITU and the Russian Space Agency. She was involved in research activities including NASA-IFA cooperation for climatological-meteorological matters, development of innovative products for alternative energy and agriculture). She is author of more than 50 international papers.
Mr Dimitriou has 30 years’ experience in the Pharmaceutical and Biotech industry and is a co-founder and former CEO of a listed biotech company. He held global business development roles at GlaxoSmithKline and Bristol Myers-Squibb, spent 8 years at Procter & Gamble in Marketing, R&D and Business Development and began his career at Novartis in 1987. He is the founder and President of Dragon Finance AG and DyoDelta Biosciences Ltd.; advisory companies specializing in life sciences. Dimitri has a Bachelor in Biochemistry from Kings College, a Masters in Pathology from Imperial College and is a member of numerous scientific societies.
Dr Pavesi holds a PhD in Physics and has almost 40 years’ experience in high technology industries. She worked in advanced technology for 28 years in Telespazio, a Leonardo Company, as Director of Business Development and Innovative Services and other roles. Prior to this, she worked at Italspazio, Consortium for Space Activities, directing and leading international studies and projects for NASA, ESA, ITU and the Russian Space Agency. She was involved in research activities including NASA-IFA cooperation for climatological-meteorological matters, development of innovative products for alternative energy and agriculture). She is author of more than 50 international papers.
Mr Werlé is the Founder of the international investments company Quantrum AG with over 20 years’ experience on the Boards of Companies in a range of industries, including food and catering, medical tourism and luxury hospitality, and asset management. Currently Mr Werlé serves as Vice-Chairman of Nimo Holding AG; Chairman of Asserta Management AG and of Grand Resort Bad Ragaz AG. He is also a Member of the Board of Directors of Cat Holding AG and FORMIA Asia Pacific (a Hong-Kong based company). Past positions include: Board member of Swiss Post, Vice-Chairman of the specialty food company Aryzta (2008), CEO of the Hiestand Group and of SAirRelations. Mr Werlé Studied Business Management at the University of Applied Sciences of Frankfurt/Main, Germany and began his career at Deutsche Lufthansa AG.
Mr Wirz can look back over a 40-year career with Nestlé Group in different positions of responsibility, including leadership roles in finance, accounting and operations in a number of South American countries, the UK and Spain. He served as Chief Financial Officer and Senior Vice President of Nestlé S.A, Switzerland and was a Director of Nestlé Health Science S.A. Past positions also include Board member of Nestlé Capital Advisers, Intercona Reinsurance AG, Alcon Inc. (US listed) and SIX (Swiss Stock Exchange). Currently Mr Wirz serves as Director and Head of the Audit Committee of SICPA Holding SA. Mr Wirz obtained a BA in Business Administration from Lucerne, and completed the Programme for Executive Development at the International Institute for Management Development (IMD), Lausanne.
Kim has 20 years of consultancy working with international companies to frame strategic direction; specializing in portfolio branding, consumer behaviour and data analytics. For the last 8 years she has led the Strategic Insights function of a renowned consumer goods company, specializing in emerging and transformative markets. Prior to this she spent 11 years in research agencies at the European level, specializing in product development, large scale consumer research and business strategy. She has worked with a broad portfolio of clients encompassing FMCG, Travel, Retail and Luxury, renowned corporations such as Unilever, Nestlé, Danone, Reckitt Benckiser, Givaudan, Procter & Gamble, L’Oréal, Chanel, Shiseido and Carrefour. Ms. Marty obtained a BSc in Mathematics and Business from the University of Leeds and has completed various Executive Development programs from Business Schools in Europe and the USA.
Dr Kourniaktis is an entrepreneur and business innovator, with over 7 years’ experience in virtual operations, project and communications’ management. An historian by training and formerly a Teaching Fellow at the University of Oxford, since 2017 she has held various roles in Swiss life sciences start-ups encompassing communications, operations, corporate secretarial and process innovation functions. She is the founder and CEO of Manage Mind AG, a management services partner for innopreneurial businesses, COO of Laevoroc Oncology AG and former COO of SynDermix AG.
Dr Kourniaktis earned her DPhil from the University of Oxford, holds an MA from University College London and a BA from the University of Bristol. She was awarded the Emerging Life Sciences CEO Award (Europe) in CEO Monthly magazine’s 2022 Global CEO Excellence Awards.
Mr Werlé is the Founder of the international investments company Quantrum AG with over 20 years’ experience on the Boards of Companies in a range of industries, including food and catering, medical tourism and luxury hospitality, and asset management. Currently Mr Werlé serves as Vice-Chairman of Nimo Holding AG; Chairman of Asserta Management AG and of Grand Resort Bad Ragaz AG. He is also a Member of the Board of Directors of Cat Holding AG and FORMIA Asia Pacific (a Hong-Kong based company). Past positions include: Board member of Swiss Post, Vice-Chairman of the specialty food company Aryzta (2008), CEO of the Hiestand Group and of SAirRelations. Mr Werlé Studied Business Management at the University of Applied Sciences of Frankfurt/Main, Germany and began his career at Deutsche Lufthansa AG.
Mr Wirz can look back over a 40-year career with Nestlé Group in different positions of responsibility, including leadership roles in finance, accounting and operations in a number of South American countries, the UK and Spain. He served as Chief Financial Officer and Senior Vice President of Nestlé S.A, Switzerland and was a Director of Nestlé Health Science S.A. Past positions also include Board member of Nestlé Capital Advisers, Intercona Reinsurance AG, Alcon Inc. (US listed) and SIX (Swiss Stock Exchange). Currently Mr Wirz serves as Director and Head of the Audit Committee of SICPA Holding SA. Mr Wirz obtained a BA in Business Administration from Lucerne, and completed the Programme for Executive Development at the International Institute for Management Development (IMD), Lausanne.
Dr Kourniaktis is an entrepreneur and business innovator, with over 7 years’ experience in virtual operations, project and communications’ management. An historian by training and formerly a Teaching Fellow at the University of Oxford, since 2017 she has held various roles in Swiss life sciences start-ups encompassing communications, operations, corporate secretarial and process innovation functions. She is the founder and CEO of Manage Mind AG, a management services partner for innopreneurial businesses, COO of Laevoroc Oncology AG and former COO of SynDermix AG.
Dr Kourniaktis earned her DPhil from the University of Oxford, holds an MA from University College London and a BA from the University of Bristol. She was awarded the Emerging Life Sciences CEO Award (Europe) in CEO Monthly magazine’s 2022 Global CEO Excellence Awards.
© 2023 ESGTI AG. All rights reserved · Legal Notice · Privacy Policy